Exchange transfusions are invasive and associated with considerable morbidity and mortality (estimated to occur in 50 and 3 per 1,000 procedures, respectively) [1 , 10].
Underestimation of bilirubin levels may result in undertreatment, possibly contributing to a re-emergence of bilirubin neurotoxicity in jaundiced infants [8].